Diamond Information Institute (TCEL) SEC Filing 8-K Material Event for the period ending Thursday, March 18, 2010

Therapy Cells Inc

CIK: 1429859 Ticker: TCEL

View differences made from one to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.


Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: TCEL
CIK: 1429859
Form Type: 8-K Corporate News
Accession Number: 0001092306-10-000131
Submitted to the SEC: Mon Mar 29 2010 7:21:55 PM EST
Accepted by the SEC: Tue Mar 30 2010
Period: Thursday, March 18, 2010
Industry: Wholesale Jewelry Watches Precious Stones And Metals
  1. Change in Control
  2. Event for Officers
  3. Financial Exhibit
  4. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: